Press "Enter" to skip to content

trenbolone enanthate gains

Local vasoconstriction of the nasal mucosa and sinuses occurs in 5-10 minutes after injection trenbolone enanthate gains into the nasal cavity, and lasts up to 10-12 hours. Acute allergic rhinitis, or infectious and inflammatory etiology, sinusitis, nasal congestion and shortness of nasal breathing in colds, evstahiit, otitis media. For ease of manipulation and other rinoskopii in the nasal cavity.

Contraindications

Hypersensitivity to the drug; atrophic rhinitis; pregnancy and lactation; Children up to age 6 years.

Precautions
To use caution in the drug in chronic heart failure, arrhythmias, atherosclerosis, hypertension, hyperthyroidism, diabetes mellitus, chronic renal failure, angle-closure glaucoma, prostatic hyperplasia, with clinical symptoms; concomitant use of monoamine oxidase inhibitors, tricyclic antidepressants.

To prevent the spread of infection, do not use one vial of several persons. Avoid long-term use and overdose. Prolonged use of decongestants may reduce their effectiveness. Misuse of these funds can cause atrophy of the nasal mucosa and reactive hyperemia with drug rhinitis.

Application of pregnancy and lactation.

During pregnancy and lactation the drug is used in case of emergency, when the expected benefit to the mother outweighs the potential risk to the fetus or infant.

Dosage and administration.

The tip of the nozzle trenbolone enanthate gains of the vial is administered in each nostril and sharply pressed once per vial. During injection the air drawn into the nose. Do not reject his head back and turn the vial by injecting Nokspreya.

Children aged 6 to 12 years of use 1 injection in each nostril 2 times a day, children over 12 and adults – 1-2 injections in each nostril 2 times a day. Duration of treatment should not exceed 7 days.

Side effect.

Sometimes – a burning sensation or dryness of the nasal membranes, sneezing. In rare cases – reactive hyperemia. Multiple overdose by topical nasal application leads to systemic sympathomimetic effects such as tachycardia, insomnia, restlessness, increased blood pressure, headache, nausea.
It is extremely rare in the application Nokspreya may develop severe hypersensitivity reactions, including angioedema. In case of any side effects of the drug should be discontinued and seek medical advice.

Overdose.

With substantial overdose or accidental oral route may experience these symptoms: cramps, nausea, vomiting, cyanosis, hyperthermia, tachycardia, arrhythmia, vascular insufficiency, hypertension, respiratory disorders, pulmonary edema, heart failure, mental disorders. Very rarely – depression of the central nervous system with the possible development of coma. If overdose is washed stomach and symptomatic therapy.

The interaction with other drugs. Noksprey not be used simultaneously with other local vasoconstrictive agents and agents for intranasal administration, as well as tricyclic antidepressants and monoamine oxidase inhibitors.

Use in children
Noksprey used in children from 6 years.

Effects on ability to drive vehicles, mechanisms
In the recommended doses, the drug does not affect the speed of psychomotor reactions.

release Form

20 ml vials with plastic trenbolone enanthate gains stoppers, lids and spray to control the first opening.
The bottle with instruction on the medical application are placed in a pile of cardboard. men’s health